Table 4.
Summary of genetic toxicity thresholds in vivo of EMS
| Reference | Animals | Tissue | Endpoint | PoD (mg/kg bw/d) | |
|---|---|---|---|---|---|
| NOGEL | BMDL | ||||
| Cao et al | gpt−delta mice | Lung | gpt gene mutation | 5 | 0.56 |
| Kidney | gpt gene mutation | 5 | 0.59 | ||
| Spleen | gpt gene mutation | 13 | 0.35 | ||
| Bone marrow | gpt gene mutation | 20 | 0.37 | ||
| Small intestine | gpt gene mutation | 20 | 0.55 | ||
| Liver | Micronucleus | 55 | 2.3 | ||
| Peripheral blood | Pig−a gene mutation RET | 5 | 1.18 | ||
| Pig−a gene mutation RBC | 20 | 4.67 | |||
| Micronucleus RET on 13d | 20 | 6.79 | |||
| Micronucleus RET on 29d | 55 | 8.26 | |||
| Gocke et al | MutaTMmice | Bone marrow | lacZ gene mutation | 50 | 9.29 |
| Liver | lacZ gene mutation | 50 | 41 | ||
| Small intestine | lacZ gene mutation | 25 | 12.3 | ||
| CD1 mice | Bone marrow | Micronucleus RET on 7d | 80 | 58.7 | |
Abbreviations: RBC red blood cell, RET reticulocytes, NOGEL no observed genotoxic effect level, BMDL the lower bound of benchmark dose